Mural cell dysfunction contributes to diastolic heart failure by promoting endothelial dysfunction and vessel

Mandy O J Grootaert1,2, Alessandra Pasut3, Jana Raman4

  • 1Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, box 911, Leuven, 3000, Belgium. mandy.grootaert@kuleuven.be.

PubMed

Insights

Mural cell dysfunction contributes to heart failure with preserved ejection fraction (HFpEF) by impairing blood vessels. This dysfunction reduces endothelial cell proliferation and promotes inflammation, driving HFpEF progression.

Area of Science:

  • Cardiovascular Research
  • Metabolic Disease Research
  • Vascular Biology

Background:

  • Heart failure with preserved ejection fraction (HFpEF) is linked to metabolic issues.
  • Endothelial cell (EC) dysfunction is implicated in HFpEF, but mural cell roles are unknown.

Purpose of the Study:

  • Investigate mural cell dysfunction in a novel HFpEF mouse model.
  • Determine the contribution of mural cells to HFpEF pathophysiology.

Main Methods:

  • Utilized a diabetic db/db mouse model with high salt intake.
  • Employed single-cell RNA sequencing, NicheNet analysis, and histology.
  • Labeled mural cells using genetic tools for detailed analysis.

Main Results:

  • Diabetic mice developed diastolic dysfunction, capillary loss, and pericyte loss.
  • EC dysfunction and increased pericyte-EC space were observed early.
  • Mural cells, not ECs, strongly signaled to ECs, inducing growth arrest via TNFα.

Conclusions:

  • Mural cell dysfunction is a key contributor to HFpEF.
  • Mural cells induce coronary vessel remodeling by inhibiting EC proliferation and promoting inflammation.
  • TNFα-dependent paracrine signaling from mural cells plays a critical role.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K